![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Avita Medical Announces Completion of Enrollment in ReCell Trial for Vitiligo
Avita Medical Announces Completion of Enrollment in ReCell Trial for Vitiligo
August 21, 2013
Avita Medical has completed enrollment of patients in a trial that will evaluate its ReCell for recurrence of abnormal skin pigmentation caused by vitiligo.
Yahoo! Finance
Yahoo! Finance
Upcoming Events
-
21Oct